MD Anderson Cancer Center's faculty has asked the UT System to freeze the salaries of Ronald DePinho and members of his executive team until they reach a level of parity with faculty salaries, according to a white paper presented to UT System Chancellor Bill McRaven June 14.
The Oncology Research Information Exchange Network July 9 announced the addition of three cancer institutions to its precision cancer research partnership, bring the total number of partners to nine.
Three cancer centers have been awarded comprehensive status from NCI, the highest designation possible: the Huntsman Cancer Institute at the University of Utah, UT Southwestern's Harold C. Simmons Cancer Center, and the University of New Mexico Cancer Center.
FDA has often asked ODAC members to discuss broad scientific questions. However, the approval questions have, without an exception, been shoehorned into the up-or-down dichotomy.
The FDA Oncologic Drugs Advisory Committee July 9 appears to have recommended approval for the Eli Lilly and Co. agent necitumumab.Yes, the word “appears” has indeed appeared in the previous sentence.
The Cancer Letter won a first place 2015 National Press Club Award in the NPC's annual journalism competition June 26.
The NCI Board of Scientific Advisors approved the following concepts at a meeting June 24:
The Senate Committee on Appropriations June 25 approved the fiscal 2016 Labor, Health and Human Services, and Education Appropriations Bill, which would boost NIH's budget to $32 billion—an increase of $2 billion above fiscal 2015.
The following is a transcript of NCI Acting Director Douglas Lowy's remarks to the joint meeting of the National Cancer Advisory Board and the NCI Board of Scientific Advisors, June 24:
Is new money on the way to NCI? It's certainly been promised in President Obama's budget proposal and in the appropriations bills gestating in the House and Senate.
